Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

AstraZeneca Truqap plus Faslodex recommended for approval in EU by CHMP for advanced ER-positive breast cancer

Written By Ruchika Sharma1 May 2024 11:30 AM IST

Cambridge: AstraZeneca's Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been recommended for approval in the...

AstraZeneca admits 'very rare' side effect of COVID vaccine in UK court

Written By Ruchika Sharma30 April 2024 6:00 PM IST

London: AstraZeneca (AZ), a pharmaceutical giant headquartered in the UK, has acknowledged that in "very rare cases," its coronavirus vaccine can...

CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR Data

Glenmark Pharma gets USFDA nod for Acetaminophen and Ibuprofen Tablets

Written By Ruchika Sharma30 April 2024 5:50 PM IST

New Jersey: Glenmark Pharmaceuticals Ltd. has received final approval from the United States Food & Drug Administration (U.S. FDA)...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Diabetes drug: Sanofi unveils Soliqua in India

Written By Ruchika Sharma30 April 2024 2:35 PM IST

Soliqua is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting basal insulin and lixisenatide, a...

Granules India arm gets USFDA nod for Gout flares drug Colchicine

Written By Ruchika Sharma30 April 2024 11:30 AM IST

Colchicine Capsules are indicated for prophylaxis of gout flares in adults.

Gland Pharma profit rises 12 percent to Rs 184 crore in Q2

Gland Pharma bags USFDA nod for Cetrorelix Acetate for Injection

Written By Ruchika Sharma29 April 2024 3:06 PM IST

Cetrorelix Acetate for Injection is used to prevent premature LH surges in women undergoing controlled ovarian stimulation.

Prior Intimation System Under NDCT Rules Wont Apply to Hormones, Cytotoxics, Beta-Lactams, Certain Biologics: CDSCO

India becoming attractive for clinical trials: Pharma industry leaders

Written By Ruchika Sharma29 April 2024 2:33 PM IST

New Delhi: Experts from the pharmaceutical sector have noted that over the last decade, clinical trials in India have undergone significant...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

JnJ gets positive CHMP opinion for Rybrevant, chemotherapy combo for first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations

Written By Ruchika Sharma28 April 2024 12:30 PM IST

Belgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...

Global Fund expands commitment to improve access to HIV drug

USFDA approves Biktarvy label update with data for pregnant adults with HIV: Gilead Sciences

Written By Ruchika Sharma28 April 2024 11:30 AM IST

Foster City: Gilead Sciences, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved an updated label with additional data...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

EMA Committee recommends nod for Bristol Myers Squibb Opdivo in combination with Cisplatin, Gemcitabine for Urothelial Carcinoma

Written By Ruchika Sharma28 April 2024 11:30 AM IST

Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

Pfizer Secures Vyndamax Patent Till 2031

USFDA nod to Pfizer Beqvez for adults with Hemophilia B

Written By Ruchika Sharma27 April 2024 12:09 PM IST

New York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ (fidanacogene elaparvovec-dzkt) for the...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

Zydus Lifesciences bags USFDA nod for acne cream Tretinoin

Written By Ruchika Sharma27 April 2024 11:39 AM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok